11.12.2012 Views

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

400<br />

Fig. 4. HER-2/neu, score 3+, Cdi (40x).<br />

Fig. 5. C-erbB2 gene amplification.<br />

Results. There was no statistical significance for HR expression<br />

(Figg. 1-2) in two subsets (pT1ab VS pT1c, χ 2 p:0.897). A high<br />

proliferative activity (Fig. 3) was detected in 75.7% and 24.3%<br />

respectively for pT1c and pT1a-b (τ-test, p:0.002). HER2/Neu<br />

was positive (IHC, FISH, Figg. 4-5) in 22/187 (11.8%) cases<br />

of pT1c and in 9/105 (8.5%) cases of pT1a-b; the proliferative<br />

activity index was high in both HER2/Neu + subset (τ-test,<br />

p:0.985). Follow up data (mean FU: 56.3 months; range 9-108<br />

months) were available in 22/31 patients HER2/Neu + (8<br />

pT1a-b, 14 pT1c). Two relapses (9.1%) 4 were observed: the<br />

first (pT1b, G3, high Ki-67 treated only with radio-therapy),<br />

recurred both locally and on visceral sites; the second patient<br />

(pT1c, G2, high Ki-67 treated only with hormonal therapy)<br />

showed a triple negative biological features on a re-biopsy performed<br />

on liver metastases.<br />

Conclusion. We observed that different Ki-67 expression 5 , in<br />

two subset (pT1a-b vs pT1c), is associated with tumor size and<br />

this difference is lost in HER2/Neu positive cases regardless of<br />

tumor size (τ-test, p:0.985). We concluded that HER2/neu overexpression/amplification,<br />

could represent a significant marker<br />

of high risk of relapse and could be a prognostic and predictive<br />

factor also in pT1N0M0 breast cancer 6 .<br />

references<br />

1 Neville AM, et al. J Clin Oncol;10:696-705.<br />

2 Sánchez-Muñoz A et al. Breast Journal;17:32-8.<br />

3 Wolff AC, et al. Arch Pathol Lab Med 2007;131:18-43.<br />

4 Joensuu H, et al. Clin Cancer Res 2003;9:923-30.<br />

5 Colleoni M, et al. Annals of Oncology;15:1633-9.<br />

6 Curigliano G, et al. J Clin Oncol 2009;<strong>27</strong>:5693-9.<br />

CONGRESSO aNNualE di aNatOmia patOlOGiCa SiapEC – iap • fiRENzE, 25-<strong>27</strong> OttOBRE <strong>2012</strong><br />

OSSO E PArTI MOLLI<br />

Angiomyomatous hamartoma of the left inguinocrural<br />

area: a case report<br />

M.P. Brisigotti1 , F. Sarocchi1 , P. Calamaro1 , M. Bruzzone1 ,<br />

F. Spagnolo3 , F. Cafiero4 , M. Trapasso3 , L. Moresco4 , B. Spina2 1 University of Genoa, Histhopathology, DISC, Azienda Ospedaliera e<br />

Universitaria San Martino-IRCCS-IST, Genoa; 2 National Institute of<br />

Cancer Research (IST), Pathology Unit, Azienda Ospedaliera e Universitaria<br />

San Martino-IRCCS-IST, Genoa; 3 National Institute of Cancer Research<br />

(IST), Plastic Surgery Unit, Azienda Ospedaliera ed Universitaria<br />

San Martino-IRCCS-IST, Genoa; 4 National Institute of Cancer Research<br />

(IST), Surgical Oncology Unit, Azienda Ospedaliera ed Universitaria San<br />

Martino-IRCCS-IST, Genoa<br />

Introduction. Angiomyomatous hamartoma (AMH) of the<br />

lymph node is a benign vascular disorder and has been described<br />

as a primary vascular tumor characterized by the replacement of<br />

lymph node tissue by blood vessels, smooth muscle and fibrous<br />

tissue in a sclerotic lymphatic stroma. These tumors of unknown<br />

etiology, first described by Chan et al in 1992, are rare disease<br />

and they usually involve inguinal and femoral lymph nodes.<br />

Materials and methods. The patient is a 29 year old woman with<br />

left inguino crural poli-adenopathy and a single painfull mass,<br />

deep in the layers above the femoral nerve and vessels, developed<br />

over the last three months. Color Doppler Ultrasound and MRI<br />

revealed a solid mass measuring 2,5 cm with low vascular supply<br />

and regular margins. A pre-operative lymphoscintigraphy showed<br />

abnormalities in the lymph node flow in the inguino-crural and<br />

pelvic lymph nodes. The mass was clinically diagnosed as a<br />

schwannoma. Since the tumor gradually enlarged, wide excision<br />

of the mass was performed.<br />

Results. The gross specimen was composed of fibro-adipose tissue<br />

measuring 8 x 4 x 2 cm in the contest of which there was a<br />

nodular single mass measuring 2 cm that, on cut section had a firm,<br />

gray-white appearance (Fig. 1). The specimen was extensively<br />

sampled for histologic examination. Microscopically on routine<br />

hematoxylin and eosin stains the nodular mass was a lymph node<br />

with a peripheral rim of normal lymphoid tissue, with few residual<br />

follicles, which was almost completely replaced by a proliferation<br />

of numerous thick-walled muscular blood vessels (Fig. 2). This<br />

proliferation was associated with haphazardly arranged bundles of<br />

smooth muscle cells within a sclerotic stroma. There were also few<br />

compressed lobules of benign adipocytes. None of the constituent<br />

cells displayed cytologic atypia. Mitoses and necrosis were absent.<br />

On immunohistochemical stains there was a strong reactivity for<br />

smooth muscle actin (SMA) (Fig. 3) and desmin (Fig. 4) in the<br />

spindle shaped cells dispersed throughout the fibrous tissue confirming<br />

the muscular origine of these elements.<br />

Morphological and immunohistochemical results lead to a diagnosis<br />

of an angiomyomatous hamartoma.<br />

Fig. 1.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!